Advertisement
Screener

GOSSAMER BIO, INC. (GOSS) Depreciation

GOSSAMER BIO, INC. Depreciation

GOSSAMER BIO, INC. (GOSS) reported Depreciation of $9.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Cash Flow › Operating Activities

us-gaap:Depreciation · last filed 2026-08-13

  • GOSSAMER BIO, INC. depreciation for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
  • GOSSAMER BIO, INC. depreciation for fiscal 2024 was $800.00K, a 50.00% decline from fiscal 2023.
  • GOSSAMER BIO, INC. depreciation for fiscal 2023 was $1.60M, a 11.11% decline from fiscal 2022.
  • GOSSAMER BIO, INC. depreciation for fiscal 2022 was $1.80M, a 5.88% increase from fiscal 2021.
Period endDepreciation 6 monthDepreciation 12 month
2026-06-30$9.00K
10-Q · filed 2026-08-13
2025-12-31$0.00
10-K · filed 2026-03-17
2025-06-30$12.00K
10-Q · filed 2026-08-13
2024-12-31$800.00K
10-K · filed 2026-03-17
2023-12-31$1.60M
10-K · filed 2026-03-17
2022-12-31$1.80M
10-K · filed 2025-03-13
2021-12-31$1.70M
10-K · filed 2024-03-05
2020-12-31$1.40M
10-K · filed 2023-03-17
2019-12-31$900.00K
10-K · filed 2022-03-03
2018-12-31$300.00K
10-K · filed 2021-02-26
2017-12-31$0.00
10-K · filed 2020-03-24

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cogent Biosciences, Inc. (COGT)United States$5.450B-17.61
PTC THERAPEUTICS, INC. (PTCT)United States$5.199B-177.07
Dianthus Therapeutics, Inc. /DE/ (DNTH)United States$5.082B-27.79
Erasca, Inc. (ERAS)United States$5.073B-19.96
Oruka Therapeutics, Inc. (ORKA)United States$5.663B-43.76
Travere Therapeutics, Inc. (TVTX)United States$5.712B-123.10
Mirum Pharmaceuticals, Inc. (MIRM)United States$5.798B-8.81
Veradermics, Inc (MANE)United States$4.839B
Edgewise Therapeutics, Inc. (EWTX)United States$4.470B-22.23
Amneal Pharmaceuticals, Inc. (AMRX)$6.326B25.62